drug manufacturers news from FierceHealthcare
NewsCMS to mandate drug, device makers reporting on provider relationships
The Centers for Medicare & Medicaid Services (CMS) yesterday proposed a Sunshine Act transparency rule, in which drug and device manufacturers must disclose information about their relationships Read more...
Harvard docs punished for conflict of interest violations; ties to pharma
Physicians and drug makers walk a fine line when it comes to their relationships with each other. For three psychiatrists affiliated with Massachusetts General Hospital and Harvard Medical School in Read more...
Drug shortages cost providers $200M annually
Ninety percent of hospitals and other healthcare organizations encountered prescription drug shortages during the second half of 2010, with at least 80 percent indicating the shortages resulted in Read more...
Generic drugmakers protest paying in for health reform
Looked at it one way, generic drug manufacturers are getting quite a break when it comes to financing health reform. Under the Senate Finance Committee bill approved last week, the hospital industry Read more...
FDA: We want to release more information
The FDA has taken steps to do something it hasn't done much of in the past--maintain more of an open-door policy where key drug and enforcement information is concerned. FDA commissioner Margaret Read more...
ALSO NOTED: US drugmakers face financial downgrades next year; Providers getting on board with NPI quickly; and much more...
> Next year could be a grim one financially for U.S. drug manufacturers, who can expect to see their credit ratings drop thanks to patent expirations, generic competition and regulatory Read more...
Express Scripts pays $9.5M settlement over drug switching
Pharmacy benefit manager Express Scripts has agreed to pay a total of $9.5 million to 28 states and the District of Columbia to settle allegations that it engaged in deceptive prescription-switching Read more...
SPOTLIGHT: FDA can't manage foreign drugmaker inspections
A new report from the Government Accountability Office has concluded that the FDA doesn't have the resources to properly inspect foreign companies that manufacture drugs or drug ingredients. At Read more...
| Press ReleasesWe Can’t Wait: Obama Administration makes more progress to reduce, prevent drug shortagesIn response to President Obama’s Executive Order, FDA issues rule requiring manufacturers to report interruptions in production of critical drugs WASHINGTON--(BUSINESS WIRE)-- Today, in response to Read more >> Specialist Physicians’ Consulting Fees in Europe and United States Differ by 13%, According to Cutting Edge Information StFMV rates converging as companies pursue transparency and global strategy RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Drug manufacturers pay US physicians 13% higher rates for the same consulting Read more >> For the Treatment of Mutated EGFR Non-Small-Cell Lung Cancer, the Majority of Surveyed European Oncologists Indicate ThatIn Order to Justify a High Cost for Treatment, Interviewed European Payers Assert That Drug Makers Must Define the Patient Population That Will Benefit Most from a Novel Therapy, According to a New Read more >> AHF Seeks 20% Price Cut from AIDS Drug Companies for State ProgramMore Than 5,500 Patients Remain on Waiting Lists to Receive Lifesaving Medications Through State AIDS Drug Assistance Programs (ADAP); Additional Cost-Containment Measures May Mean Thousands More Read more >> Seniors Group Asks All in Drug Distribution Chain to Help Protect Patients from Unapproved Products60 Plus applauds FDA’s removal of untested colchicine from market, but reminds that more work is needed to protect patient safety ALEXANDRIA, Va.--(BUSINESS WIRE)-- James L. Martin, chairman of the Read more >> |
